Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2013
10/15/2013US8558004 Reagents and kits for detection of influenza virus and the like
10/15/2013US8558003 Imaging tracers for early detection and treatment of amyloid plaques caused by Alzheimer's disease and related disorders
10/15/2013US8558002 Sulfoximines as kinase inhibitors
10/15/2013US8558001 Compounds for the treatment of addiction
10/15/2013US8558000 4-pyridinone compounds and their use for cancer
10/15/2013US8557999 Pharmaceutical, dietary supplement, and food grade salts of anatabine
10/15/2013US8557997 Biphenyl compounds useful as muscarinic receptor antagonists
10/15/2013US8557996 Heteroaryl-substituted alkyne compounds and method of use
10/15/2013US8557995 Solid dispersions containing kinase inhibitors
10/15/2013US8557994 Deuterium-enriched pyridinonecarboxamides and derivatives
10/15/2013US8557993 Crystalline forms of pitavastatin calcium
10/15/2013US8557992 Heterocyclic fused phenanthrolinone M1 receptor positive allosteric modulators
10/15/2013US8557982 Tubulin polymerisation inhibitors
10/15/2013US8557979 Carbapenem antibacterials with gram-negative activity and processes for their preparation
10/15/2013US8557978 Cross-linked glycopeptide-cephalosporin antibiotics
10/15/2013US8557968 Biotinylated hexadecasaccharides, preparation and use thereof
10/15/2013US8557873 Method for treating septic shock or endotoxemia
10/15/2013US8557872 Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
10/15/2013US8557871 Dermatological compositions comprising retinoids, dispersed benzoyl peroxide and carrageenans
10/15/2013US8557870 Methods of treatment utilizing topical emulsion-gel composition comprising diclofenac sodium
10/15/2013US8557869 Compositions and methods for promoting fat loss
10/15/2013US8557868 Ophthalmic and contact lens solutions using low molecular weight amines
10/15/2013US8557867 Inhibitors of NCCa-ATP channels for therapy
10/15/2013US8557866 Isomeric mixtures of dinitro-octylphenyl esters and synergistic fungicidal mixtures therefrom
10/15/2013US8557865 Methods for treating osteoarthritis
10/15/2013US8557864 Agent having neurotrophic factor-like activity
10/15/2013US8557863 Suppression and prevention of tumors
10/15/2013US8557861 Low oil emulsion compositions for delivering taxoids and other insoluble drugs
10/15/2013US8557860 Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
10/15/2013US8557859 Immunomodulatory compositions
10/15/2013US8557858 (E)-N-(2-amino-phenyl)-3-{1-[4-(l-methyl-1H-pyrazol-4-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide salts
10/15/2013US8557857 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
10/15/2013US8557856 Etomidate analogues with improved pharmacokinetic and pharmacodynamic properties
10/15/2013US8557855 Methods of using ryanodine antagonists in treating neural injury
10/15/2013US8557854 Use of a sulfonamide compound for improving the pharmacokinetics of a drug
10/15/2013US8557853 Aryl fluoroethyl ureas acting as alpha 2 adrenergic agents
10/15/2013US8557852 Methods of using crystalline forms of a salt of a factor Xa inhibitor
10/15/2013US8557851 Combinations of flupirtine and sodium channel inhibiting substances for treating pains
10/15/2013US8557848 4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
10/15/2013US8557847 Synergistic modulation of FLT3 kinase using a FLT3 inhibitor and a farnesyl transferase inhibitor
10/15/2013US8557846 Medicinal treatment of dermal diseases in dogs
10/15/2013US8557845 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
10/15/2013US8557844 Substrate reduction therapy
10/15/2013US8557843 Quinoline derivatives and their use as tyrosine kinase inhibitors
10/15/2013US8557842 Cocaine analogs and methods of preparation and uses thereof
10/15/2013US8557841 Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/15/2013US8557840 Herbicidal compounds
10/15/2013US8557839 Fused ring azadecalin glucocorticoid receptor modulators
10/15/2013US8557837 Sinomenine derivatives, synthetic methods and uses thereof
10/15/2013US8557836 Spiro-piperidine inhibitors
10/15/2013US8557835 Statin-carboxyalkylether combinations
10/15/2013US8557834 Prolyl hydroxylase inhibitors
10/15/2013US8557833 Aminopyrimidines useful as kinase inhibitors
10/15/2013US8557832 Aryl methyl benzoquinazolinine M1 receptor positive allosteric modulators
10/15/2013US8557830 RAF kinase modulators and methods of use
10/15/2013US8557829 Use of allopurinol for the treatment of palmar plantar erythrodysesthesia
10/15/2013US8557828 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
10/15/2013US8557825 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/15/2013US8557824 Thiazole derivatives
10/15/2013US8557823 Family of PFKFB3 inhibitors with anti-neoplastic activities
10/15/2013US8557822 Carboxamide, sulfonamide and amine compounds and methods for using the same
10/15/2013US8557821 Microbiocidal heterocycles
10/15/2013US8557820 Crystal modifications of transmission dyes
10/15/2013US8557819 Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
10/15/2013US8557818 Compounds useful as protein kinase inhibitors
10/15/2013US8557817 Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
10/15/2013US8557816 Aurora kinase modulators and method of use
10/15/2013US8557815 Substituted triazolophthalazine derivatives
10/15/2013US8557814 mTOR inhibitor salt forms
10/15/2013US8557813 2-benzylpyridazinone derivatives as met kinase inhibitors
10/15/2013US8557812 Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereof
10/15/2013US8557811 Dual-color imaging method of sodium/calcium activities using two-photon fluorescent probes and preparation method of two-photon fluorescent probes
10/15/2013US8557810 Imidazolothiazole compounds for the treatment of disease
10/15/2013US8557809 Triazolopyridine compounds as PIM kinase inhibitors
10/15/2013US8557808 Selective beta-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents
10/15/2013US8557807 Thienopyranones as kinase inhibitors
10/15/2013US8557806 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
10/15/2013US8557805 Fused ring compound and use thereof
10/15/2013US8557804 Nicotinic receptor agonists for the treatment of inflammatory diseases
10/15/2013US8557803 Purinone derivative
10/15/2013US8557802 Amide derivative
10/15/2013US8557801 Compounds and compositions useful for the treatment of parasitic diseases
10/15/2013US8557800 Sphingosine kinase inhibitors
10/15/2013US8557799 Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy
10/15/2013US8557798 Macrocyclic heterocyclic aspartyl protease inhibitors
10/15/2013US8557797 Triazolopyridine derivatives and their therapeutic use
10/15/2013US8557796 Substituted 1-oxa-2,8-diaza-spiro [4,5] dec-2-ene derivatives and related treatment methods
10/15/2013US8557794 Immunemodulating oligosaccharides
10/15/2013US8557793 Theanine derivative, preparation method thereof, and use thereof for alleviating acne
10/15/2013US8557792 Method of treating vitamin B12 deficiency
10/15/2013US8557791 Anti-tumor agent comprising cytidine derivative and carboplatin
10/15/2013US8557790 A3 adenoside receptor agonists for the reduction of intraocular pressure
10/15/2013US8557789 Method of treating inflammatory arthropathies with supressors of CPG oligonucleotides
10/15/2013US8557785 In vivo production of small interfering RNAS that mediate gene silencing
10/15/2013US8557784 Glycyrrhizinates of morphinan derivatives
10/15/2013US8557783 Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders
10/15/2013US8557782 Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
10/15/2013US8557763 Synthetic peptides that enhance tight junction permeability
10/15/2013US8557515 Compositions and methods for cancer diagnosis and therapy
10/15/2013US8557301 Oral rehydration composition
1 ... 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 ... 7860